Lipids: Potential regulators of nitric oxide generation

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 3 50-3, 2004, Pages

  Chikani, Gentle ^a   Zhu, Weifei ^a   Smart, Eric J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Caveolae; Caveolin; Cholesterol; Oxidized low density lipoprotein

Indexed keywords

CAVEOLIN; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANGIOGENESIS; BLOOD CLOTTING; BLOOD VESSEL TONE; CAVEOLA; ENDOTHELIUM CELL; ENZYME ACTIVITY; FIBRINOLYSIS; HORMONAL REGULATION; HUMAN; LIPID METABOLISM; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; CAVEOLAE; CHOLESTEROL; CHOLESTEROL, HDL; ESTRADIOL; HUMANS; LIPID METABOLISM; LIPOPROTEINS, LDL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III;

EID: 4143147354     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00106.2004     Document Type: Short Survey

References (42)

1. Acton SL, Scherer PE, Lodish HF, and Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 269: 21003-21009, 1994.
2. Babitt J, Trigatti B, Rigotti A, Smart EJ, Anderson RG, Xu S, and Krieger M. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem 272: 13242-13249, 1997.
3. Blair A, Shaul PW, Yuhanna IS, Conrad PA, and Smart EJ. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem 274: 32512-32519, 1999.
4. Brown MS and Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52: 223-261, 1983.
5. Caulin-Glaser T, Garcia-Cardena G, Sarrel P, Sessa WC, and Bender JR. 17 Beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. Circ Res 81: 885-892, 1997.
6. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 30: 325-333, 1997.
7. Chambliss KL and Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 23: 665-686, 2002.
8. Chambliss KL and Shaul PW. Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae. Steroids 67: 413-419, 2002.
9. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, and Shaul PW. ERbeta has nongenomic action in caveolae. Mol Endocrinol 16: 938-946, 2002.
10. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, and Shaul PW. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 87: E44-E52, 2000.
11. Daugherty A. Mouse models of atherosclerosis. Am J Med Sci 323: 3-10, 2002.
12. Dzau VJ, Gibbons GH, Cooke JP, and Omoigui N. Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives. Circulation 87: 705-719, 1993.
13. Feron O, Dessy C, Moniotte S, Desager JP, and Balligand JL. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103: 897-905, 1999.
14. Feron O, Michel JB, Sase K, and Michel T. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. Biochemistry 37: 193-200, 1998.
15. Furchgott RF and Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
16. Furuchi T and Anderson RG. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem 273: 21099-21104, 1998.
17. Ghosh S, Gachhui R, Crooks C, Wu C, Lisanti MP, and Stuehr DJ. Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis. J Biol Chem 273: 22267-22271, 1998.
18. Gong M, Wilson M, Kelly T, Su W, Dressman J, Kincer J, Matveev SV, Guo L, Guerin T, Li XA, Zhu W, Uittenbogaard A, and Smart EJ. HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 111: 1579-1587, 2003.
19. Gordon DJ and Rifkind BM. High-density lipoprotein-the clinical implications of recent studies. N Engl J Med 321: 1311-1316, 1989.
20. Griffith OW and Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol 57: 707-736, 1995.
21. Grundy SM. Cholesterol and coronary heart disease. A new era. JAMA 256: 2849-2858, 1986.
22. Hayashi T, Fukuto JM, Ignarro LJ, and Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA 89: 11259-11263, 1992.
23. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, Hidaka H, and Iguchi A. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 214: 847-855, 1995.
24. Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N, and Murata Y. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 276: 3459-3467, 2001.
25. Huwiler A, Kolter T, Pfeilschifter J, and Sandhoff K. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta 1485: 63-99, 2000.
26. Igarashi J, Thatte HS, Prabhakar P, Golan DE, and Michel T. Calcium-independent activation of endothelial nitric oxide synthase by ceramide. Proc Natl Acad Sci USA 96: 12583-12588, 1999.
27. Ignarro LJ. Endothelium-derived nitric oxide: actions and properties. FASEB J 3: 31-36, 1989.
28. Kauser K and Rubanyi GM. Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol Heart Circ Physiol 267: H2311-H2317, 1994.
29. Kincer JF, Uittenbogaard A, Dressman J, Guerin TM, Febbraio M, Guo L, and Smart EJ. Hypercholesterolemia promotes a CD36-dependent and endothelial nitric-oxide synthase-mediated vascular dysfunction. J Biol Chem 277: 23525-23533, 2002.
30. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, and Shaul PW. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol Lung Cell Mol Physiol 273: L119-L126, 1997.
31. Li XA, Titlow WB, Jackson BA, Giltiay N, Nikolova-Karakashian M, Uittenbogaard A, and Smart EJ. High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner. J Biol Chem 277: 11058-11063, 2002.
32. Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF, and Sargiacomo M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 126: 111-126, 1994.
33. Michel JB, Feron O, Sacks D, and Michel T. Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem 272: 15583-15586, 1997.
34. Mineo C, Yuhanna IS, Quon MJ, and Shaul PW. High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem 278: 9142-9149, 2003.
35. Moncada S and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
36. O'Donnell VB and Freeman BA. Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ Res 88: 12-21, 2001.
37. Rigotti A, Acton SL, and Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 270: 16221-16224, 1995.
38. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RG, and Michel T. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271: 6518-6522, 1996.
39. Stefano GB, Prevot V, Beauvillain JC, Cadet P, Fimiani C, Welters I, Fricchione GL, Breton C, Lassalle P, Salzet M, and Bilfinger TV. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 101: 1594-1597, 2000.
40. Uittenbogaard A, Shaul PW, Yuhanna IS, Blair A, and Smart EJ. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J Biol Chem 275: 11278-11283, 2000.
41. Vane JR, Anggard EE, and Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 323: 27-36, 1990.
42. Yuhanna IS, Zhu Y, Cox BE, Hahner LD, Osborne-Lawrence S, Lu P, Marcel YL, Anderson RG, Mendelsohn ME, Hobbs HH, and Shaul PW. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med 7: 853-857, 2001.